Insiders · LPTX

LPTX insider transactions

Leap Therapeutics Inc. (LPTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LPTX

• 202d
  SEC Form 4 filed by CEO,CFO,Pres.,GC,Treas.&Sec. Onsi Douglas E

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Li William

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Richard Christian M

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Mashiach Nissim

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Martin Patricia A.

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Schilsky Richard

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Loscalzo Joseph

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Cavanaugh James H

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Mirabelli Christopher

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Dietz Thomas John

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 4 filed by Director Oei Khing Djien

  4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 202d
  SEC Form 3 filed by new insider Oei Khing Djien

  3 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
• 337d
  SEC Form 4 filed by Chief Scientific Officer Baum Jason

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 337d
  SEC Form 4 filed by Chief Operating Officer Lawlor Augustine

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 337d
  SEC Form 4 filed by Chief Manufacturing Officer O'Mahony John Mark

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  CEO,CFO,Pres.,GC,Treas.&Sec. Onsi Douglas E converted options into 32,500 shares, increasing direct ownership by 44% to 106,146 units (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  VP, Head of Reg Affairs/Qual Granfield Christine converted options into 22,500 shares and covered exercise/tax liability with 6,604 shares (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  Chief Scientific Officer Baum Jason covered exercise/tax liability with 6,604 shares and converted options into 22,500 shares (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  Chief Operating Officer Lawlor Augustine converted options into 22,500 shares and covered exercise/tax liability with 7,797 shares, increasing direct ownership by 289% to 19,789 units (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  Chief Manufacturing Officer O'Mahony John Mark converted options into 22,500 shares, increasing direct ownership by 450% to 27,500 units (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  Chairman of the Board Mirabelli Christopher converted options into 22,500 shares and covered exercise/tax liability with 6,672 shares, increasing direct ownership by 311% to 20,914 units (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 428d
  Chief Medical Officer Sirard Cynthia converted options into 22,500 shares, increasing direct ownership by 450% to 27,500 units (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 565d
  Director Cavanaugh James H exercised 213 in-the-money shares at a strike of $2.82 (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 565d
  CEO,CFO,Pres.,GC,Treas.&Sec. Onsi Douglas E exercised 2,136 in-the-money shares at a strike of $2.82 (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 565d
  Chief Operating Officer Lawlor Augustine exercised 2,136 in-the-money shares at a strike of $2.82 (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 565d
  Chairman of the Board Mirabelli Christopher exercised 2,136 in-the-money shares at a strike of $2.82 (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by VP, Head of Reg Affairs/Qual Granfield Christine

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Chief Medical Officer Sirard Cynthia

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Schilsky Richard

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Richard Christian M

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Martin Patricia A.

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by CEO,CFO,Pres.,GC,Treas.,&Sec. Onsi Douglas E

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Loscalzo Joseph

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Li William

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Chief Manufacturing Officer O'Mahony John Mark

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Chief Operating Officer Lawlor Augustine

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Dietz Thomas John

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Cavanaugh James H

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Mirabelli Christopher

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Chief Scientific Officer Baum Jason

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 607d
  SEC Form 4 filed by Director Mashiach Nissim

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 775d
  New insider Gilead Sciences, Inc. claimed ownership of 5,319,148 shares (SEC Form 3)

  3 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Mashiach Nissim

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Schilsky Richard

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Dietz Thomas John

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Granfield Christine

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Richard Christian M

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Baum Jason

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by O'Mahony John Mark

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Sirard Cynthia

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Martin Patricia A.

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Lawlor Augustine

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Loscalzo Joseph

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Mirabelli Christopher

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Onsi Douglas E

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Li William

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 854d
  SEC Form 4 filed by Cavanaugh James H

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 855d
  Mirabelli Christopher converted options into 5,000 shares, increasing direct ownership by 5,814% to 5,086 units (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 855d
  O'Mahony John Mark converted options into 5,000 shares (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)
• 855d
  Sirard Cynthia converted options into 5,000 shares (SEC Form 4)

  4 - LEAP THERAPEUTICS, INC. (0001509745) (Issuer)